Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-7.52%
↑ 79% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-36.22%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -7.52% |
| 2024 | -57.55% |
| 2023 | -24.66% |
| 2022 | -49.20% |
| 2021 | 29.11% |
| 2020 | -15.35% |
| 2019 | -104.06% |
| 2018 | -30.79% |
| 2017 | -30.65% |
| 2016 | -71.55% |